Maternal use of hormonal contraception and risk of childhood leukemia: A Scandinavian population-based cohort study

Gastrointestinal Cancer

Oral contraceptive use and risk of liver cancer: a population-based study, systematic review, and meta-analysis

Lancet Oncol

Watling CZ, Sweetland S, Wojt A, Butera G, Graubard BI, Floud S, Matthews CE, Reeves GK, McGlynn KA

doi: 10.1016/S1470-2045(25)00222-0

Central Nervous System Tumors

Hormonal contraceptives and the risk of meningioma: a Swedish register-based case-control study

Neuro Oncol

Tettamanti G, Shu X, Mogensen H, Kopp Kallner H, Mathiesen T, Feychting M

doi: 10.1093/neuonc/noaf228

Gastrointestinal Cancer

Panacreatic cancer risk after benign gallbladder disease: A Swedish population-based cohort study

Eur J Cancer

Radkiewicz C, Ludvigsson JF, Sparrelid E, Emilsson L

doi: 10.1016/j.ejca.2024.115140

Lung, Respiratory and Thoracic Cancer

Polygenic risk score to define risk of cancer-associated thrombosis among patients with lung cancer in a population-based study

Lung Cancer

Tafur A, Sebai A, Shi Z, Wei J, Tran H, Zheng SL, Krantz S, Hensing T, Mansfield AS, Xu J

doi: 10.1016/j.lungcan.2025.108712

Gynecologic Cancer

Oncological outcomes after radical hysterectomy followed by adjuvant (chemo)radiation or no further treatment in women with cervical cancer FIGO 2018 IB2-IIA2 - A multinational population-based cohort study

Eur J Cancer

Hardie AN, Wenzel HHB, Schnack TH, Van der Aa MA, Jensen PT, Bekkers RLM, Falconer H, Dutch, dANish and sweDish gynaEcoLogIcal ONcology (DANDELION) research group

doi: 10.1016/j.ejca.2025.115664

Gastrointestinal Cancer

Survival benefit of adjuvant chemotherapy in elderly patients with UICC stage III colon carcinoma: A 20-year population-based German cohort study

Eur J Cancer

Langheinrich M, Gerken M, Robers G, Hansinger J, Franke B, Lacruz ME, Mueller-Nordhorn J, Schneider C, Reinwald F, Stang A, Sackmann A, Zeissig SR, Klinkhammer-Schalke M, Kersting S, Völkel V, Benz S

doi: 10.1016/j.ejca.2025.115583

Breast Cancer

Outcomes based on risk-adapted adjuvant therapy in postmenopausal women with early breast cancer: a nationwide, prospective cohort study by the Danish Breast Cancer Group

Lancet Oncol

Jensen MB, Torpe E, Teunissen Z, Taarnhøj G, Brix E, Knoop A, Yammeni S, Donskov F, Ejlertsen B

doi: 10.1016/S1470-2045(25)00085-3

Myeloproliferative Neoplasms (MPNs)

Impact of age and time since diagnosis on thrombosis risk in myeloproliferative neoplasm patients: A nationwide register-based matched cohort study

Br J Haematol

Batyrbekova N, Hultcrantz M, Ravn Landtblom A, Szulkin R, Dickman PW, Andersson TM, Syriopoulou E

doi: 10.1111/bjh.20141

Lymphoma

A comparative analysis of transformed indolent lymphomas and de novo diffuse large B-cell lymphoma: a population-based cohort study

Blood Cancer J

Vaughn JL, Ramdhanny A, Munir M, Rimmalapudi S, Epperla N

doi: 10.1038/s41408-024-01194-5

Related content

Oral contraceptive use and risk of liver cancer: a population-based study, systematic review, and meta-analysis

Hormonal contraceptives and the risk of meningioma: a Swedish register-based case-control study

Panacreatic cancer risk after benign gallbladder disease: A Swedish population-based cohort study

Polygenic risk score to define risk of cancer-associated thrombosis among patients with lung cancer in a population-based study

Oncological outcomes after radical hysterectomy followed by adjuvant (chemo)radiation or no further treatment in women with cervical cancer FIGO 2018 IB2-IIA2 - A multinational population-based cohort study

Survival benefit of adjuvant chemotherapy in elderly patients with UICC stage III colon carcinoma: A 20-year population-based German cohort study

Outcomes based on risk-adapted adjuvant therapy in postmenopausal women with early breast cancer: a nationwide, prospective cohort study by the Danish Breast Cancer Group

Impact of age and time since diagnosis on thrombosis risk in myeloproliferative neoplasm patients: A nationwide register-based matched cohort study

A comparative analysis of transformed indolent lymphomas and de novo diffuse large B-cell lymphoma: a population-based cohort study